PDF-ThromboGenics
Resubmits BLA for Ocriplasmin with the FDA
Leuven Belgium x2013
1
7
April 2012
x2013
ThromboGenics NV Euronext Brussels THR a biopharmaceutical company focused on
Download Presentation
"ThromboGenics" is the property of its rightful owner. Permission is granted to download and print materials on this website for personal, non-commercial use only, provided you retain all copyright notices. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Transcript not available.